
BTSG Stock Forecast & Price Target
BTSG Analyst Ratings
Bulls say
BrightSpring Health is a leader in the specialty drug market, showing strong financial performance and growth potential through acquisitions and market expansion. However, competition and potential regulatory changes in drug pricing pose risks. Nonetheless, BTSG's recent debt reduction and market cap growth make it a promising investment in the specialty pharmacy industry.
Bears say
BrightSpring Health is expected to see high-teens core adjusted EBITDA growth through 2028, with a strong LRP and track record of beating or raising growth expectations. However, risks include potential competition in the specialty pharmacy market, changes in reimbursement rates, and the significant ownership stake held by private equity firm KKR. Despite these risks, BTSG remains a leader in a growing industry with a strong focus on delivering high-quality care and reducing the total cost of care for high-need patients.
This aggregate rating is based on analysts' research of BrightSpring Health Services Inc and is not a guaranteed prediction by Public.com or investment advice.
BTSG Analyst Forecast & Price Prediction
Start investing in BTSG
Order type
Buy in
Order amount
Est. shares
0 shares